Site-specific integrating recombinant aav vectors for gene therapy and improved production methods
AssigneeUniversity of Florida Research Foundation, Inc.
InventorsArun Srivastava, Chen Ling
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of site-specific integration of a heterologous sequence into a host genome (e.g., by administering a recombinant adeno-associated virus (rAAV) to a host cell in the presence of a Rep protein), and methods for treating diseases and disorders by delivering an rAAV that comprises a nucleic acid vector comprising a Rep protein. Also provided herein are methods and compositions for producing rAAV particles with improved titer and transduction efficiencies.
Claims20
A method of promoting site-specific nucleic acid integration into a host genome, the method comprising:
- delivering a recombinant adeno-associated virus (rAAV) particle comprising a nucleic acid vector to a host cell in the presence of a Rep protein.
20-35. (canceled)
Dependencies are inferred from the claim text.